Health Catalyst Inc 2025年季度报告

(Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period endedMarch31, 2025 Or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number:001-38993 HEALTH CATALYST, INC.(Exact name of registrant as specified in its charter)________________ Delaware 45-3337483(I.R.S. EmployerIdentification Number) (State or other jurisdiction ofincorporation or organization) 10897 South River Front Parkway #300South JordanUT84095(Address of principal executive offices, including zip code) (801)708-6800(Registrant’s telephone number, including area code)________________ Securities registered pursuant to Section 12(b) of the Act: Name of exchange on which registered The Nasdaq Global Select Market Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to suchfiling requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit suchfiles).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, oran emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growthcompany” in Rule 12b-2 of the Exchange Act. Large accelerated filer☐Accelerated Filer☒Emerging growthcompanyNon-accelerated Filer☐Smaller reporting company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any newor revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ As of May5, 2025, the Registrant had69,601,233shares of common stock outstanding. HEALTH CATALYST, INC. Special Note Regarding Forward-looking Statements As used in this Quarterly Report on Form 10-Q, unless expressly indicated or the context otherwise requires, references to “HealthCatalyst,” “we,” “us,” “our,” “the Company,” and similar references refer to Health Catalyst, Inc. and its consolidated subsidiaries. ThisQuarterly Report on Form 10-Q, including the section titled “Management’s Discussion and Analysis of Financial Condition and Results ofOperations,” includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (theSecurities Act), and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). Forward-looking statements areonly predictions based on our management’s beliefs and assumptions and on information currently available to our management. Allstatements other than statements of historical facts are “forward-looking statements” for purposes of these provisions, including thoserelating to future events or our future financial performance and financial guidance. These forward-looking statements, which are subjectto a number of risks, uncertainties, and assumptions, generally relate to future events or our future financial or operating performance. Insome cases, you can identify these statements by forward-looking words such as “believe,” “may,” “will,” “estimate,” “continue,”“anticipate,” “design,” “intend,” “expect,” “could,” “plan,” “potential,” “predict,” “seek,” “should,” “would,” “target,” “project,” or“contemplate,” the negative of terms like these or other comparable terminology, and other words or terms of similar meaning inconnection with any discussion of expectations, projections, plans, strategy, intentions, or future results of operations or financialperformance. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to, statementsabout our: •ability to attract new clients and retain and expand our relationships with existing clients;•ability to expand our service offerings, develop new platform features, and rollout and migrate existing DOS clients to our newplatform, Health Catalyst Ignite; •future financial performance, including trends in revenue, costs of revenue, gross margin, operating expenses, and cost structure;•ability to compete successfully in competitive markets;•ability to respond to rapid technological changes;•expectations and management of future growth and strategic changes;•ability to enter new markets and ma